Skin is a barrier that keeps body water in and microorganisms and noxious chemicals out. Topical drugs, the mainstay of treatment in dermatology, are applied in the hope and expectation that any percutaneous absorption will be minimal and that systemic side effects will not occur. It is becoming apparent though that skin is not quite as impermeable as often believed. Undoubtedly, drugs can be absorbed through the skin and produce either unwanted or intended systemic effects.
Mechanism of percutaneous absorption'
The superficial layers of the epidermis, the stratum corneum, provide almost all the skin's barrier properties. (The basal epidermal layers and the underlying dermis are readily permeable-the often used term 'transdermal absorption' is inaccurate.) The stratum corneum is made up of layers of overlapping cell plates containing the fibrous protein keratin. Most drug absorption is transcellular: it is unlikely that noticeable absorption occurs between cells or through sweat pores and hair follicles. It is a passive diffusion process, the magnitude of which will depend on the integrity and efficacy of the epidermal barrier but which will be influenced by the drug itself. Drugs with low molecular weight (below 800 daltons) with a high water and lipid solubility show the greatest penetration. The vehicle that contains the applied drug is important. So too is the degree of hydration of the stratum corneum: occluding the epidermis increases its water content, enhancing drug absorption.
Paediatric considerations
Size. The smaller the child the larger the surface area relative to body weight. Absorption of drugs depends on the surface area exposed, whereas distribution, metabolism, and excretion relate more to weight. Percutaneous drug absorption is therefore more important in a very low birthweight infant than in an older child. 
